Johnson & Johnson Consumer Health Presents New Data on Skincare for Cancer Patients at the American Academy of Dermatology VMX 2021
New Study Results Indicate a Daily Avena Sativa (Oat) Skincare Regimen Significantly Improves Itch and Dry Skin in Adults Undergoing Systemic Cancer Treatments
News provided by
Share this article
Share this article
SKILLMAN, N.J., April 23, 2021 /PRNewswire/ Johnson & Johnson Consumer Health today presented findings from one of the first clinical studies examining a daily skincare regimen as adjunctive therapy for cancer patients at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021. The study shows a daily Avena Sativa (Oat) skincare regimen provided a significant improvement in xerosis and pruritus (dry skin and itch) for adult patients undergoing systemic oncology treatments, indicating Aveeno Restorative Skin Therapy is safe and effective for the management of mild-to-moderate itch and/or dry skin related to system
Johnson & Johnson Consumer Health Presents New Data on Skincare for Cancer Patients at the American Academy of Dermatology VMX 2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.